Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Minerva Neurosciences (NERV) has provided an update.
Jeryl Hilleman will step down from her position on the Board and Chair of the Audit Committee at Minerva Neurosciences, effective August 6, 2024, to pursue other opportunities, with no disagreements prompting her departure. Jan van Heek will assume the role of Chair, and Dr. David Kupfer will join the Audit Committee following Hilleman’s resignation.
See more data about NERV stock on TipRanks’ Stock Analysis page.